News

  1. Home
  2. News

María José Alonso receives the National Research Award ‘Juan de la Cierva’

The ‘Juan de la Cierva Award’ is the most important prize granted by the Government of Spain in the area of Technology Transfer

Check out our new OPEN ACCESS publication: ‘Quantification of the actual composition of polymeric nanocapsules: a quality control analysis’

Berrecoso, G., Crecente-Campo, J. & Alonso, M.J. Quantification of the actual composition of polymeric nanocapsules: a quality control analysis. Drug Deliv. and Transl. Res. (2022). https://doi.org/10.1007/s13346-022-01150-5

Grants for Master Degree Courses “Master in Drug Research and Development”

Grants for Master Degree Courses “Master in Drug Research and Development” DEADLINE: 24/03/2022 Link to information    

María José Alonso, distinguished with the National Research Award ‘Juan de la Cierva’ 2021, granted by the Spanish Ministry of Science and Innovation

The ‘Juan de la Cierva Award’ is the most important prize granted by the Government of Spain in the area of Technology Transfer

DIAGBI: Theranostics of brain tumors using immuno-radiopharmaceuticals and nanotechnology

María José Alonso's Lab participates in the DIAGBI project for the early and non-invasive diagnosis of brain tumors. The main objective of DIAGBI is to develop a new technology that allows early diagnosis and non-invasive monitoring of the most aggressive brain tumors, glioblastomas, using immuno-PET techniques.

Check out our new OPEN ACCESS publication: ‘Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA’

In our lab we are exploring the potential of the nose-to-brain drug delivery route for the transport of RNA molecules. Check this review article showing where we are now in this field

Nanotechnologies for the delivery of biologicals: historical perspective and current landscape

Do you consider yourself a supporter or detractor of nanotechnology-based drug delivery? Do you believe nanotechnology may contribute to the successful exploitation...

María José Alonso, once again recognized for her research career in the field of Nanotechnology

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has just been recognized with the first ‘Nanotechnology Award’ granted by the company NOB166, for her research career in the field of Biopharmacy.

Check out our OPEN ACCESS publication: ‘Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery’

Check out our recent paper published OPEN ACCESS in Drug Delivery and Translational Research, and official journal of the Controlled Release Society (CRS). In this work, we focused on an immunostimulant beta-glucan derivative, carboxymethyl-β-glucan, to prepare a novel nanocarrier in combination with chitosan.

María José Alonso and Libera Bio, awarded by the US National Foundation for Cancer Research with the third prize of the 2021 Salisbury Award Competition

Founded by Professor Alonso, Libera Bio is a company developing a novel delivery vector of whole monoclonal antibodies to intracellular cancer targets otherwise deemed “undruggable”. The Salisbury Award Competition is designed to catalyze and advance promising cancer research innovations onto a path of commercialization and patient impact.